# Perimeter Solutions, Inc.: financial statements, quarterly

PRM · NYSE · CIK 1880319 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prm.md) · [Financials](/companies/prm/financials.md) · [Filings](/companies/prm/filings.md) · [Insiders](/companies/prm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [143](/filings/0001880319-24-000105.md) | [59.5 d](/filings/0001880319-26-000013.md) | [59.0](/filings/0001880319-25-000068.md) | [127](/filings/0001880319-25-000107.md) | [288](/filings/0001880319-25-000129.md) | [86.2 d](/filings/0001880319-26-000013.md) | [72.0](/filings/0001880319-26-000037.md) | [163](/filings/0001880319-26-000048.md) | [315](/filings/0001880319-25-000129.md) | [103 d](/filings/0001880319-26-000013.md) | [125](/filings/0001880319-26-000037.md) | [214](/filings/0001880319-26-000048.md) |
| Cost of revenue | $m | [72.8](/filings/0001880319-24-000105.md) | [40.7 d](/filings/0001880319-26-000013.md) | [38.3](/filings/0001880319-25-000068.md) | [54.0](/filings/0001880319-25-000107.md) | [107](/filings/0001880319-25-000129.md) | [44.3 d](/filings/0001880319-26-000013.md) | [43.9](/filings/0001880319-26-000037.md) | [61.1](/filings/0001880319-26-000048.md) | [116](/filings/0001880319-25-000129.md) | [56.4 d](/filings/0001880319-26-000013.md) | [74.3](/filings/0001880319-26-000037.md) | [95.9](/filings/0001880319-26-000048.md) |
| Gross profit | $m | [69.8](/filings/0001880319-24-000105.md) | [18.7 d](/filings/0001880319-26-000013.md) | [20.7](/filings/0001880319-25-000068.md) | [73.3](/filings/0001880319-25-000107.md) | [181](/filings/0001880319-25-000129.md) | [41.9 d](/filings/0001880319-26-000013.md) | [28.2](/filings/0001880319-26-000037.md) | [101](/filings/0001880319-26-000048.md) | [199](/filings/0001880319-25-000129.md) | [46.4 d](/filings/0001880319-26-000013.md) | [50.8](/filings/0001880319-26-000037.md) | [118](/filings/0001880319-26-000048.md) |
| Selling, general and administrative | $m | [12.7](/filings/0001880319-24-000105.md) | [13.6 d](/filings/0001880319-26-000013.md) | [13.5](/filings/0001880319-25-000068.md) | [13.9](/filings/0001880319-25-000107.md) | [18.5](/filings/0001880319-25-000129.md) | [21.0 d](/filings/0001880319-26-000013.md) | [16.3](/filings/0001880319-26-000037.md) | [16.0](/filings/0001880319-26-000048.md) | [23.5](/filings/0001880319-25-000129.md) | [21.8 d](/filings/0001880319-26-000013.md) | [23.1](/filings/0001880319-26-000037.md) | [27.0](/filings/0001880319-26-000048.md) |
| Operating income | $m | [27.2](/filings/0001880319-24-000105.md) | [(8.9) d](/filings/0001880319-26-000013.md) | [(74.9)](/filings/0001880319-25-000068.md) | [45.0](/filings/0001880319-25-000107.md) | [(35.2)](/filings/0001880319-25-000129.md) | [61.3 d](/filings/0001880319-26-000013.md) | [77.8](/filings/0001880319-26-000037.md) | [(26.2)](/filings/0001880319-26-000048.md) | [(87.3)](/filings/0001880319-25-000129.md) | [(165) d](/filings/0001880319-26-000013.md) | [72.5](/filings/0001880319-26-000037.md) | [(203)](/filings/0001880319-26-000048.md) |
| Interest expense | $m | [10.4](/filings/0001880319-23-000110.md) | [10.4 d](/filings/0001880319-24-000007.md) | [10.6](/filings/0001880319-24-000045.md) | [10.6](/filings/0001880319-25-000107.md) | [10.1](/filings/0001880319-25-000129.md) | [9.2 d](/filings/0001880319-26-000013.md) | [9.6](/filings/0001880319-26-000037.md) | [9.9](/filings/0001880319-26-000048.md) | [9.9](/filings/0001880319-25-000129.md) | [9.7 d](/filings/0001880319-26-000013.md) | [24.4](/filings/0001880319-26-000037.md) | [19.6](/filings/0001880319-26-000048.md) |
| Income tax | $m | [3.8](/filings/0001880319-24-000105.md) | [(4.1) d](/filings/0001880319-26-000013.md) | [(4.3)](/filings/0001880319-25-000068.md) | [12.5](/filings/0001880319-25-000107.md) | [45.1](/filings/0001880319-25-000129.md) | [(94.2) d](/filings/0001880319-26-000013.md) | [12.5](/filings/0001880319-26-000037.md) | [(1.7)](/filings/0001880319-26-000048.md) | [(6.5)](/filings/0001880319-25-000129.md) | [(34.2) d](/filings/0001880319-26-000013.md) | [(23.1)](/filings/0001880319-26-000037.md) | [(39.8)](/filings/0001880319-26-000048.md) |
| Net income | $m | [19.3](/filings/0001880319-24-000105.md) | [(13.2) d](/filings/0001880319-26-000013.md) | [(82.6)](/filings/0001880319-25-000129.md) | [21.7](/filings/0001880319-25-000129.md) | [(89.2)](/filings/0001880319-25-000129.md) | [144 d](/filings/0001880319-26-000013.md) | [56.7](/filings/0001880319-26-000048.md) | [(32.2)](/filings/0001880319-26-000048.md) | [(90.7)](/filings/0001880319-25-000129.md) | [(140) d](/filings/0001880319-26-000013.md) | [72.9](/filings/0001880319-26-000048.md) | [(182)](/filings/0001880319-26-000048.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001880319-24-000105.md) | not reported | [(0.57)](/filings/0001880319-25-000068.md) | [0.14](/filings/0001880319-25-000107.md) | [(0.61)](/filings/0001880319-25-000129.md) | not reported | [0.36](/filings/0001880319-26-000037.md) | [(0.22)](/filings/0001880319-26-000048.md) | [(0.62)](/filings/0001880319-25-000129.md) | not reported | [0.44](/filings/0001880319-26-000037.md) | [(1.11)](/filings/0001880319-26-000048.md) |
| Basic EPS | $ per share | [0.13](/filings/0001880319-24-000105.md) | not reported | [(0.57)](/filings/0001880319-25-000068.md) | [0.15](/filings/0001880319-25-000107.md) | [(0.61)](/filings/0001880319-25-000129.md) | not reported | [0.38](/filings/0001880319-26-000037.md) | [(0.22)](/filings/0001880319-26-000048.md) | [(0.62)](/filings/0001880319-25-000129.md) | not reported | [0.47](/filings/0001880319-26-000037.md) | [(1.11)](/filings/0001880319-26-000048.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [71.8](/filings/0001880319-23-000110.md) | [47.3](/filings/0001880319-25-000021.md) | [34.4](/filings/0001880319-24-000045.md) | [43.2](/filings/0001880319-24-000062.md) | [223](/filings/0001880319-24-000105.md) | [198](/filings/0001880319-26-000013.md) | [200](/filings/0001880319-25-000068.md) | [141](/filings/0001880319-25-000107.md) | [341](/filings/0001880319-25-000129.md) | [326](/filings/0001880319-26-000048.md) | [91.6](/filings/0001880319-26-000037.md) | [82.8](/filings/0001880319-26-000048.md) |
| Current assets | $m | [294](/filings/0001880319-23-000110.md) | [251](/filings/0001880319-25-000021.md) | [237](/filings/0001880319-24-000045.md) | [295](/filings/0001880319-24-000062.md) | [439](/filings/0001880319-24-000105.md) | [394](/filings/0001880319-26-000013.md) | [385](/filings/0001880319-25-000068.md) | [420](/filings/0001880319-25-000107.md) | [584](/filings/0001880319-25-000129.md) | [564](/filings/0001880319-26-000048.md) | [398](/filings/0001880319-26-000037.md) | [496](/filings/0001880319-26-000048.md) |
| Total assets | $m | [2,360](/filings/0001880319-23-000110.md) | [2,315](/filings/0001880319-25-000021.md) | [2,279](/filings/0001880319-24-000045.md) | [2,322](/filings/0001880319-24-000062.md) | [2,462](/filings/0001880319-24-000105.md) | [2,416](/filings/0001880319-26-000013.md) | [2,405](/filings/0001880319-25-000068.md) | [2,486](/filings/0001880319-25-000107.md) | [2,645](/filings/0001880319-25-000129.md) | [2,653](/filings/0001880319-26-000048.md) | [3,164](/filings/0001880319-26-000037.md) | [3,245](/filings/0001880319-26-000048.md) |
| Current liabilities | $m | [63.5](/filings/0001880319-23-000110.md) | [55.1](/filings/0001880319-25-000021.md) | [62.6](/filings/0001880319-24-000045.md) | [81.9](/filings/0001880319-24-000062.md) | [112](/filings/0001880319-24-000105.md) | [62.5](/filings/0001880319-26-000013.md) | [73.7](/filings/0001880319-25-000068.md) | [104](/filings/0001880319-25-000107.md) | [264](/filings/0001880319-25-000129.md) | [175](/filings/0001880319-26-000048.md) | [129](/filings/0001880319-26-000037.md) | [316](/filings/0001880319-26-000048.md) |
| Total liabilities | $m | [1,183](/filings/0001880319-23-000110.md) | [1,163](/filings/0001880319-25-000021.md) | [1,227](/filings/0001880319-24-000045.md) | [1,246](/filings/0001880319-24-000062.md) | [1,462](/filings/0001880319-24-000105.md) | [1,259](/filings/0001880319-26-000013.md) | [1,189](/filings/0001880319-25-000068.md) | [1,308](/filings/0001880319-25-000107.md) | [1,534](/filings/0001880319-25-000129.md) | [1,520](/filings/0001880319-26-000048.md) | [1,960](/filings/0001880319-26-000037.md) | [2,223](/filings/0001880319-26-000048.md) |
| Long-term debt | $m | [666](/filings/0001880319-23-000110.md) | [666](/filings/0001880319-25-000021.md) | [667](/filings/0001880319-24-000045.md) | [667](/filings/0001880319-24-000062.md) | [667](/filings/0001880319-24-000105.md) | [668](/filings/0001880319-26-000013.md) | [668](/filings/0001880319-25-000068.md) | [668](/filings/0001880319-25-000107.md) | [669](/filings/0001880319-25-000129.md) | [669](/filings/0001880319-26-000048.md) | [1,210](/filings/0001880319-26-000037.md) | [1,210](/filings/0001880319-26-000048.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,177](/filings/0001880319-24-000105.md) | [1,152](/filings/0001880319-26-000013.md) | [1,052](/filings/0001880319-25-000129.md) | [1,075](/filings/0001880319-25-000129.md) | [1,000](/filings/0001880319-25-000129.md) | [1,157](/filings/0001880319-26-000048.md) | [1,216](/filings/0001880319-26-000048.md) | [1,179](/filings/0001880319-26-000048.md) | [1,111](/filings/0001880319-25-000129.md) | [1,133](/filings/0001880319-26-000048.md) | [1,205](/filings/0001880319-26-000048.md) | [1,022](/filings/0001880319-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.7 d](/filings/0001880319-24-000105.md) | [10.4 d](/filings/0001880319-26-000013.md) | [2.8](/filings/0001880319-25-000068.md) | [8.6 d](/filings/0001880319-25-000107.md) | [183 d](/filings/0001880319-25-000129.md) | [(6.0) d](/filings/0001880319-26-000013.md) | [23.7](/filings/0001880319-26-000037.md) | [(2.9) d](/filings/0001880319-26-000048.md) | [199 d](/filings/0001880319-25-000129.md) | [18.6 d](/filings/0001880319-26-000013.md) | [(89.0)](/filings/0001880319-26-000037.md) | [(0.7) d](/filings/0001880319-26-000048.md) |
| Capital expenditure | $m | [2.3 d](/filings/0001880319-24-000105.md) | [2.8 d](/filings/0001880319-26-000013.md) | [1.6](/filings/0001880319-25-000068.md) | [3.6 d](/filings/0001880319-25-000107.md) | [3.9 d](/filings/0001880319-25-000129.md) | [6.5 d](/filings/0001880319-26-000013.md) | [4.8](/filings/0001880319-26-000037.md) | [12.8 d](/filings/0001880319-26-000048.md) | [5.0 d](/filings/0001880319-25-000129.md) | [7.0 d](/filings/0001880319-26-000013.md) | [5.8](/filings/0001880319-26-000037.md) | [12.7 d](/filings/0001880319-26-000048.md) |
| Share repurchases | $m | [10.0 d](/filings/0001880319-24-000105.md) | [26.8 d](/filings/0001880319-26-000013.md) | [14.3](/filings/0001880319-25-000068.md) | [0.1 d](/filings/0001880319-25-000107.md) | [0.0 d](/filings/0001880319-25-000129.md) | [0.0 d](/filings/0001880319-26-000013.md) | [8.2](/filings/0001880319-26-000037.md) | [32.2 d](/filings/0001880319-26-000048.md) | [0.0 d](/filings/0001880319-25-000129.md) | [0.0 d](/filings/0001880319-26-000013.md) | [0.0](/filings/0001880319-26-000037.md) | [0.0 d](/filings/0001880319-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [177](/filings/0001880319-23-000110.md) | [169](/filings/0001880319-24-000045.md) | [168](/filings/0001880319-24-000062.md) | [165](/filings/0001880319-24-000105.md) | [145](/filings/0001880319-25-000068.md) | [155](/filings/0001880319-25-000107.md) | [145](/filings/0001880319-25-000129.md) | [157](/filings/0001880319-26-000037.md) | [147](/filings/0001880319-26-000048.md) | [147](/filings/0001880319-25-000129.md) | [165](/filings/0001880319-26-000037.md) | [163](/filings/0001880319-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 163,686,923 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001880319-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.